Adagio Medical Holdings (ADGM) EGM 2026 summary
Event summary combining transcript, slides, and related documents.
EGM 2026 summary
23 Oct, 2026Opening remarks and agenda
Virtual special meeting opened at 8:00 a.m. Pacific Time on Oct. 23, 2026; one board-submitted proposal, proposal-related Q&A, then preliminary voting results.
Shares held of record on Oct. 5, 2026 were eligible; each common share carried one vote, and polls closed at 8:07 a.m. Pacific Time.
Specific resolutions to be voted on
Proposal sought approval of alternate charter amendments allowing a board-selected reverse split of common stock at a ratio from 1-for-10 to 1-for-500, inclusive.
Board and executive committee updates
Board Chair Orly Mishan presided; directors Sandra Gardiner, Keyvan Mirsaeedi-Farahani, Tim Moran and Sean Salmon attended, alongside CEO Todd Usen and CFO/Chief Business Officer Deborah Kaster.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Adagio Medical Holdings
- Proposed reverse-split authority offers Nasdaq flexibility but carries dilution and liquidity risks.ADGM
Proxy filing - Reverse-split authority seeks Nasdaq compliance amid unresolved listing deficiencies.ADGM
Proxy filing - Purpose-built VT ablation system shows strong clinical results and targets a $5.8B market.ADGM
Corporate presentation - Approval sought for a reverse stock split to maintain Nasdaq listing and address compliance issues.ADGM
Proxy filing - Net loss widened to $6.7M in Q2 2026, with no revenue and cash reserves at $7.7M.ADGM
Q2 2026 - Directors and auditor ratified with no shareholder questions; results to be filed on Form 8-K.ADGM
AGM 2026 - Ultra-low temperature VT ablation tech shows strong results and targets rapid U.S. market entry.ADGM
Small Cap Growth Virtual Investor Conference - Ultra-low temperature VT ablation tech targets $5.8B market with FDA approval expected in 2026.ADGM
25th Annual Needham Virtual Healthcare Conference - Ultra-low temperature ablation achieved 2.4% safety and 98% acute effectiveness in VT therapy.ADGM
KOL event